Drugs / Sodium Iodide I 131
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | HICON | — | 2005-05-19 | fda.gov ↗ |
| Approved | US (FDA) | IODOTOPE | — | 1957-05-02 | fda.gov ↗ |
Trials 1 · a red edge is where a trial was stopped
1956195719581959196019611962196319641965196619671968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04952493 | Sep 2021 → Jul 2023 | thyroid cancer | Peking Union Medical College Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Iodide I 131 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04952493 ↗ |